Home » Topics » Regulatory » Patents

Patents
RSS

Nitric oxide synthase inhibitors described by Hoechst

Aug. 9, 1996

UCB reports alpha-adrenergic ligands with cardiovascular activity

Aug. 9, 1996

Angiotensin II antagonists disclosed by Tanabe Seiyaku

Aug. 9, 1996

Cyclohexapeptides with multiple utilities reported by Hoechst

Aug. 9, 1996

Serine protease inhibitors in Teijin's R&D pipeline

Aug. 9, 1996

Potent 5-lipoxygenase inhibitors from Yakult Honsha

Aug. 9, 1996

NMPA and/or AMPA antagonists from Warner-Lambert

Aug. 9, 1996

NMDA antagonists claimed by E. Merck

Aug. 9, 1996

Dainippon's new compound superior to metoclopramide for digestive function improvement

Aug. 9, 1996

5-HT1A agonist with alpha1-adrenoceptor-blocking properties from Byk Gulden

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...